Status:

UNKNOWN

Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma

Lead Sponsor:

University Hospital Freiburg

Collaborating Sponsors:

Universitätsklinikum Köln

Ludwig-Maximilians - University of Munich

Conditions:

Primary Non Hodgkin Lymphoma of the Central Nervous System

Eligibility:

All Genders

65+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine whether combined chemotherapy \[rituximab plus high dosage methotrexate, lomustine, and procarbazine\] followed by maintenance therapy with procarbazine is ef...

Eligibility Criteria

Inclusion

  • first diagnosis of PCNSL, histologically confirmed
  • age \> 65 years
  • written signed and dated informed consent of the legal representative and - if possible - of the patient

Exclusion

  • manifestations of further lymphoma outside the CNS
  • sero-positive for HIV
  • severe pulmonary, cardiac, hepatic, renal impairment
  • uncontrolled infection
  • neutrophil count \< 1.500/µl, platelet count \< 100.000/µl
  • pulmonary disease with IVC \< 55%, DLCO \< 40%
  • cardiac ejection fraction \< 50%, uncontrolled malign arrhythmia
  • creatinine \> 1,5 mg% or creatinine-clearance \< 50ml/min
  • bilirubin \> 2mg/dl
  • ascites or pleural effusion (\> 500ml)
  • known hypersensitivity against methotrexate, lomustine, procarbazine, rituximab, leukovorin, or dexamethasone
  • participation in another clinical trial within the last 30 days prior to the begin or parallel to this study
  • known or current drug or alcohol abuse

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2011

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT00989352

Start Date

September 1 2009

End Date

September 1 2011

Last Update

October 5 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Medical Center Freiburg, Dept. of Internal Medicine I - Hematology and Oncology

Freiburg im Breisgau, Germany, 79106